171 related articles for article (PubMed ID: 31953506)
1. Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients.
Colombo F; Pintarelli G; Galvan A; Noci S; Corli O; Skorpen F; Klepstad P; Kaasa S; Pigni A; Brunelli C; Roberto A; Piazza R; Pirola A; Gambacorti-Passerini C; Caraceni AT
Sci Rep; 2020 Jan; 10(1):542. PubMed ID: 31953506
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.
Laugsand EA; Fladvad T; Skorpen F; Maltoni M; Kaasa S; Fayers P; Klepstad P
Eur J Cancer; 2011 Jul; 47(11):1682-91. PubMed ID: 21570824
[TBL] [Abstract][Full Text] [Related]
3. The Management of Opioid-Induced Nausea and Vomiting in Patients with Cancer: A Systematic Review.
Sande TA; Laird BJA; Fallon MT
J Palliat Med; 2019 Jan; 22(1):90-97. PubMed ID: 30239277
[TBL] [Abstract][Full Text] [Related]
4. Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting.
He H; Yin JY; Xu YJ; Li X; Zhang Y; Liu ZG; Zhou F; Zhai M; Li Y; Li XP; Wang Y; Zhou HH; Liu ZQ
Clin Ther; 2014 Aug; 36(8):1242-1252.e2. PubMed ID: 25012726
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
[TBL] [Abstract][Full Text] [Related]
6. The effects of food on opioid-induced nausea and vomiting and pharmacological parameters: a systematic review.
Raffa RB; Colucci R; Pergolizzi JV
Postgrad Med; 2017 Sep; 129(7):698-708. PubMed ID: 28635354
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of chemotherapy-induced nausea and vomiting.
Sugino S; Janicki PK
Pharmacogenomics; 2015 Jan; 16(2):149-60. PubMed ID: 25616101
[TBL] [Abstract][Full Text] [Related]
8. A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.
Singh KP; Dhruva AA; Flowers E; Kober KM; Miaskowski C
Crit Rev Oncol Hematol; 2018 Jan; 121():51-61. PubMed ID: 29279099
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?
Kanbayashi Y; Hosokawa T
J Palliat Med; 2014 Jun; 17(6):683-7. PubMed ID: 24702605
[TBL] [Abstract][Full Text] [Related]
10. Nausea and vomiting in the postoperative patient-controlled analgesia environment.
Woodhouse A; Mather LE
Anaesthesia; 1997 Aug; 52(8):770-5. PubMed ID: 9291763
[TBL] [Abstract][Full Text] [Related]
11. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
[TBL] [Abstract][Full Text] [Related]
12. Opioid induced nausea and vomiting.
Smith HS; Laufer A
Eur J Pharmacol; 2014 Jan; 722():67-78. PubMed ID: 24157979
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
[TBL] [Abstract][Full Text] [Related]
14. Economic and clinical burden of opioid-induced nausea and vomiting.
Nicholson BD
Postgrad Med; 2017 Jan; 129(1):111-117. PubMed ID: 27690715
[TBL] [Abstract][Full Text] [Related]
15. Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.
Yokoi M; Tsuji D; Suzuki K; Kawasaki Y; Nakao M; Ayuhara H; Kogure Y; Shibata K; Hayashi T; Hirai K; Inoue K; Hama T; Takeda K; Nishio M; Itoh K
Support Care Cancer; 2018 May; 26(5):1505-1513. PubMed ID: 29177570
[TBL] [Abstract][Full Text] [Related]
16. [Opioid Therapy and Management of Side Effects Associated with Opioids].
Nakatani T
Gan To Kagaku Ryoho; 2017 Apr; 44(4):294-297. PubMed ID: 28428507
[TBL] [Abstract][Full Text] [Related]
17. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
Porreca F; Ossipov MH
Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436
[TBL] [Abstract][Full Text] [Related]
18. Single-Nucleotide Polymorphisms in TAOK3 Are Associated With High Opioid Requirement for Pain Management in Patients With Advanced Cancer Admitted to a Tertiary Palliative Care Unit.
Gutteridge T; Kumaran M; Ghosh S; Fainsinger R; Klepstad P; Tarumi Y; Damaraju S; Baracos VE
J Pain Symptom Manage; 2018 Oct; 56(4):560-566. PubMed ID: 30031856
[TBL] [Abstract][Full Text] [Related]
19. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
Yamada T; Kanazawa Y; Aoki Y; Uchida E
J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
[TBL] [Abstract][Full Text] [Related]
20. Prospective observational pharmacogenetic study of side effects induced by intravenous morphine for postoperative analgesia.
Chen LK; Wang MH; Yang HJ; Fan SZ; Chen SS
Medicine (Baltimore); 2017 Jun; 96(25):e7009. PubMed ID: 28640078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
